vimarsana.com
Home
Live Updates
Genesis Capital back in clinical research with Crux Biolabs deal : vimarsana.com
Genesis Capital back in clinical research with Crux Biolabs deal : vimarsana.com
Genesis Capital back in clinical research with Crux Biolabs deal
It has cut a deal to take a controlling stake in the business, and existing owner Leading Technology Group will retain a minority position.
Related Keywords
Australia ,
Australian ,
Talbot Sayer ,
Chris Yoo ,
Michael Caristo ,
Catherine Osborne ,
Bain Co ,
Riverside Company ,
Nucleus Network ,
Southern Star Research ,
Technology Group ,
Street Talk ,
Leading Technology Group ,
Lazard Australia ,
Tunjic Legal ,
Crescent Capital Partners ,
Avance Clinical ,
Burnet Institute ,
Crescent Capital ,
Quadrant Private Equity ,
Southern Star ,
Mercury Capital ,